NASDAQ : XOMA
XOMA Royalty Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 40.17 USD (At close: Jul 13, 2026) · Market cap 710.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
XOMA Royalty Corporation (XOMA) reported revenue of 52.43M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 52.43M | 52.15M | 28.49M | 4.76M | 6.03M | 38.16M |
| Cost of Revenue | 350.00K | 1.71M | 2.88M | 143.00K | 153.00K | 171.00K |
| Gross Profit | 52.08M | 50.44M | 25.61M | 4.62M | 5.87M | 37.99M |
| Selling, General & Admin | 49.77M | 36.09M | 30.88M | 25.61M | 23.19M | 20.46M |
| Research & Development | -25.00K | |||||
| Amortization of Goodwill & Intangibles | 3.55M | 2.96M | 206.00K | 897.00K | 97.00K | |
| Operating Expenses | 73.02M | 39.05M | 31.08M | 28.08M | 23.29M | 20.46M |
| Operating Income | -20.94M | 11.38M | -5.47M | -23.46M | -17.41M | 17.53M |
| Interest Expense | -12.55M | -13.03M | -13.84M | -569.00K | -461.00K | |
| Interest & Investment Income | 1.70M | 3.47M | 6.49M | 1.69M | 694.00K | 35.00K |
| Other Non Operating Income (Expenses) | 11.07M | 5.01M | 8.40M | 40.00K | 5.00K | |
| EBT Excluding Unusual Items | -20.72M | 6.84M | -4.42M | -22.35M | -16.68M | 17.11M |
| Merger & Restructuring Charges | -3.60M | |||||
| Gain (Loss) on Sale of Investments | -1.42M | 3.75M | 131.00K | -174.00K | -439.00K | -919.00K |
| Asset Writedown | -23.55M | -14.25M | ||||
| Other Unusual Items | 24.77M | 21.22M | -11.59M | -4.06M | -300.00K | |
| Pretax Income | -20.93M | 31.82M | -19.48M | -40.83M | -17.12M | 15.89M |
| Income Tax Expense | 104.00K | 103.00K | -5.66M | -15.00K | 91.00K | |
| Net Income | -21.03M | 31.71M | -13.82M | -40.83M | -17.10M | 15.80M |
| Preferred Dividends & Other Adjustments | 7.86M | 13.20M | 5.47M | 5.47M | 5.47M | 8.01M |
| Net Income to Common | -28.89M | 18.52M | -19.29M | -46.30M | -22.58M | 7.79M |
| Shares Outstanding (Basic) | 17.73M | 12.08M | 11.70M | 11.47M | 11.41M | 11.29M |
| Shares Outstanding (Diluted) | 17.73M | 17.98M | 11.70M | 11.47M | 11.41M | 12.19M |
| EPS (Basic) | -1.63 | 1.53 | -1.65 | -4.04 | -1.98 | 0.69 |
| EPS (Diluted) | -1.63 | 1.46 | -1.65 | -4.04 | -1.98 | 0.65 |
| Free Cash Flow | -1.17M | 2.87M | -13.77M | -18.18M | -12.88M | 22.68M |
| Free Cash Flow Per Share | -0.07 | 0.16 | -1.18 | -1.58 | -1.13 | 1.86 |
| Gross Margin | 99.33% | 96.72% | 89.91% | 97.00% | 97.46% | 99.55% |
| Operating Margin | -39.95% | 21.83% | -19.21% | -493.13% | -288.93% | 45.94% |
| Profit Margin | -55.11% | 35.51% | -67.73% | -973.16% | -374.58% | 20.41% |
| Free Cash Flow Margin | -2.23% | 5.50% | -48.33% | -381.99% | -213.69% | 59.43% |
| EBITDA | -17.39M | 14.36M | -5.26M | -22.56M | -17.31M | 17.54M |
| EBITDA Margin | -33.16% | 27.53% | -18.45% | -287.21% | 45.95% | |
| D&A For EBITDA | 3.56M | 2.97M | 216.00K | 900.00K | 104.00K | 7.00K |
| EBIT | -20.94M | 11.38M | -5.47M | -23.46M | -17.41M | 17.53M |
| EBIT Margin | -39.95% | 21.83% | -19.21% | -288.93% | 45.93% | |
| Effective Tax Rate | 0.32% | 0.57% | ||||
| Revenue as Reported | 52.43M | 52.15M | 28.49M | 4.76M | 6.03M | 38.16M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 99.29M | 82.91M | 101.65M | 153.29M | 57.83M | 93.33M |
| Short-Term Investments | 842.00K | 382.00K | 3.53M | 161.00K | 335.00K | 774.00K |
| Cash & Short-Term Investments | 100.13M | 83.29M | 105.18M | 153.45M | 58.16M | 94.10M |
| Accounts Receivable | 29.41M | 27.68M | 17.02M | 15.22M | 2.37M | 209.00K |
| Receivables | 29.41M | 27.68M | 17.02M | 15.22M | 2.37M | 209.00K |
| Prepaid Expenses | 281.00K | 852.00K | 2.08M | 483.00K | 725.00K | 613.00K |
| Restricted Cash | 7.64M | 5.44M | 1.33M | 160.00K | 2.05M | |
| Total Current Assets | 137.46M | 117.26M | 125.60M | 169.31M | 61.25M | 96.97M |
| Property, Plant & Equipment | 238.00K | 277.00K | 351.00K | 403.00K | 36.00K | 213.00K |
| Long-Term Investments | 617.00K | 697.00K | ||||
| Other Intangible Assets | 19.42M | 44.76M | 25.91M | 15.15M | ||
| Long-Term Accounts Receivable | 40.31M | 60.32M | 60.91M | 57.95M | 63.68M | 69.08M |
| Other Long-Term Assets | 46.31M | 49.39M | 8.51M | 6.63M | 260.00K | 301.00K |
| Total Assets | 244.35M | 272.70M | 221.28M | 234.30M | 140.38M | 166.56M |
| Accounts Payable | 2.01M | 2.21M | 1.05M | 653.00K | 524.00K | 1.07M |
| Accrued Expenses | 5.30M | 6.69M | 5.47M | 2.77M | 2.92M | 525.00K |
| Current Portion of Long-Term Debt | 14.07M | 12.53M | 11.39M | 5.54M | ||
| Current Portion of Leases | 2.36M | 2.46M | 446.00K | 54.00K | 34.00K | 195.00K |
| Current Income Taxes Payable | 280.00K | 91.00K | ||||
| Current Unearned Revenue | 1.14M | 1.27M | 1.36M | 2.11M | 1.90M | 1.64M |
| Other Current Liabilities | 8.12M | 9.67M | 4.37M | 8.37M | 1.44M | 9.44M |
| Total Current Liabilities | 33.00M | 34.82M | 24.37M | 19.50M | 6.82M | 12.97M |
| Long-Term Debt | 89.02M | 96.45M | 106.88M | 118.52M | ||
| Long-Term Leases | 18.88M | 20.11M | 483.00K | 335.00K | 34.00K | |
| Long-Term Unearned Revenue | 2.66M | 3.19M | 4.41M | 7.23M | 9.55M | 11.69M |
| Long-Term Deferred Tax Liabilities | 103.00K | 103.00K | ||||
| Other Long-Term Liabilities | 13.41M | 14.06M | 3.21M | |||
| Total Liabilities | 157.08M | 168.74M | 139.36M | 145.58M | 16.37M | 24.69M |
| Common Stock | 133.00K | 89.00K | 90.00K | 86.00K | 86.00K | 85.00K |
| Additional Paid-In Capital | 1.35B | 1.31B | 1.30B | 1.31B | 1.31B | 1.31B |
| Retained Earnings | -1.26B | -1.22B | -1.24B | -1.22B | -1.18B | -1.17B |
| Comprehensive Income & Other | 53.00K | 73.00K | ||||
| Total Common Equity | 87.22M | 83.89M | 61.85M | 88.67M | 123.97M | 141.83M |
| Shareholders' Equity | 87.27M | 103.96M | 81.92M | 88.72M | 124.01M | 141.88M |
| Total Liabilities & Equity | 244.35M | 272.70M | 221.28M | 234.30M | 140.38M | 166.56M |
| Total Debt | 124.32M | 131.56M | 119.20M | 124.45M | 34.00K | 229.00K |
| Net Cash (Debt) | -24.19M | -48.27M | -14.02M | 29.00M | 58.13M | 93.87M |
| Net Cash Per Share | -1.36 | -2.68 | -1.20 | 2.53 | 5.09 | 7.70 |
| Filing Date Shares Outstanding | 17.73M | 11.91M | 11.98M | 11.63M | 11.46M | 11.32M |
| Total Common Shares Outstanding | 17.73M | 11.86M | 11.95M | 11.50M | 11.45M | 11.32M |
| Working Capital | 104.46M | 82.44M | 101.23M | 149.81M | 54.44M | 84.01M |
| Book Value Per Share | 4.92 | 7.07 | 5.17 | 7.71 | 10.82 | 12.53 |
| Tangible Book Value | 67.80M | 39.14M | 35.94M | 88.67M | 108.81M | 141.83M |
| Tangible Book Value Per Share | 3.82 | 3.30 | 3.01 | 7.71 | 9.50 | 12.53 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.03M | 31.71M | -13.82M | -40.83M | -17.10M | 15.80M |
| Depreciation & Amortization | 3.56M | 2.97M | 216.00K | 900.00K | 104.00K | 7.00K |
| Other Amortization | 1.21M | 1.39M | 1.35M | 34.00K | 200.00K | |
| Asset Writedown & Restructuring Costs | 23.55M | 14.25M | ||||
| Loss (Gain) From Sale of Investments | 838.00K | -3.77M | -58.00K | 174.00K | 439.00K | 919.00K |
| Stock-Based Compensation | 15.60M | 9.41M | 10.43M | 9.22M | 3.69M | 6.29M |
| Provision & Write-off of Bad Debts | 19.73M | 30.90M | 1.57M | |||
| Other Operating Activities | -30.10M | -27.47M | -39.98M | 44.00K | 170.00K | 355.00K |
| Change in Accounts Receivable | -1.58M | -2.43M | -835.00K | -1.00M | 208.00K | 54.00K |
| Change in Accounts Payable | -12.75M | -10.60M | 1.60M | -523.00K | 1.84M | 765.00K |
| Change in Unearned Revenue | -1.29M | -1.31M | -3.57M | -2.11M | -1.88M | -1.64M |
| Change in Income Taxes | -91.00K | 1.62M | ||||
| Change in Other Net Operating Assets | 1.10M | 2.96M | 18.00K | 105.00K | -266.00K | -1.68M |
| Operating Cash Flow | -1.17M | 2.87M | -13.75M | -18.16M | -12.88M | 22.68M |
| Capital Expenditures | -20.00K | -17.00K | ||||
| Cash Acquisitions | 77.87M | 69.41M | -1.25M | -15.25M | ||
| Sale (Purchase) of Intangibles | -111.00K | -20.73M | ||||
| Investment in Securities | 7.00M | 6.90M | -3.24M | |||
| Other Investing Activities | -440.00K | -4.70M | -23.75M | -694.00K | -4.97M | -26.50M |
| Investing Cash Flow | 84.32M | 50.89M | -28.26M | -711.00K | -20.22M | -26.50M |
| Long-Term Debt Issued | 130.00M | |||||
| Long-Term Debt Repaid | -10.60M | -6.90M | -21.35M | |||
| Net Debt Issued (Repaid) | -11.65M | -10.60M | -6.90M | 130.00M | -21.35M | |
| Issuance of Common Stock | 27.36M | 5.37M | 5.21M | 466.00K | 2.42M | 1.58M |
| Repurchase of Common Stock | -24.16M | -19.03M | -3.23M | -148.00K | -1.40M | -488.00K |
| Preferred Dividends Paid | -5.61M | -5.47M | -5.47M | -5.47M | -5.47M | -3.50M |
| Dividends Paid | -5.61M | -5.47M | -5.47M | -5.47M | -5.47M | -3.50M |
| Other Financing Activities | -1.03M | -752.00K | -740.00K | -4.25M | -3.41M | |
| Financing Cash Flow | -11.07M | -26.46M | -11.13M | 120.59M | -4.45M | 12.84M |
| Net Cash Flow | 72.08M | 27.29M | -53.13M | 101.72M | -37.55M | 9.01M |
| Free Cash Flow | -1.17M | 2.87M | -13.77M | -18.18M | -12.88M | 22.68M |
| Free Cash Flow Margin | -2.23% | 5.50% | -48.33% | -381.99% | -213.69% | 59.43% |
| Free Cash Flow Per Share | -0.07 | 0.16 | -1.18 | -1.58 | -1.13 | 1.86 |
| Levered Free Cash Flow | -19.63M | -14.24M | -6.02M | -10.53M | -13.30M | 26.87M |
| Unlevered Free Cash Flow | -13.00M | -7.48M | 1.28M | -10.21M | -13.30M | 26.96M |
| Cash Interest Paid | 5.83M | 11.91M | 9.98M | 311.00K | ||
| Cash Income Tax Paid | 277.00K | 277.00K | 76.00K | |||
| Change in Working Capital | -14.52M | -11.37M | -2.79M | -3.53M | -181.00K | -886.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 710.16M | 329.27M | 309.65M | 212.52M | 210.70M | 235.84M |
| Enterprise Value | 748.79M | 434.54M | 285.81M | 178.89M | 132.10M | 166.20M |
| Last Close Price | 40.17 | 26.59 | 26.28 | 18.50 | 18.40 | 20.85 |
| PE Ratio | 25.49 | 17.78 | 30.29 | |||
| Forward PE | 92.01 | 12.66 | 12.66 | 12.66 | 12.27 | |
| PS Ratio | 14.63 | 6.31 | 10.87 | 44.67 | 34.96 | 6.18 |
| PB Ratio | 5.15 | 3.17 | 3.78 | 2.40 | 1.70 | 1.66 |
| P/TBV Ratio | 14.50 | 8.41 | 8.62 | 2.40 | 1.94 | 1.66 |
| P/FCF Ratio | 104.53 | 114.69 | 10.40 | |||
| P/OCF Ratio | 104.53 | 114.69 | 10.40 | |||
| EV/Sales Ratio | 15.42 | 8.33 | 10.03 | 37.60 | 21.92 | 4.36 |
| EV/EBITDA Ratio | 90.27 | 30.27 | 9.48 | |||
| EV/EBIT Ratio | 150.51 | 38.17 | 9.48 | |||
| EV/FCF Ratio | 110.21 | 151.35 | 7.33 | |||
| Debt / Equity Ratio | 1.43 | 1.26 | 1.46 | 1.40 | 0.00 | 0.00 |
| Debt / EBITDA Ratio | 8.96 | 0.01 | ||||
| Debt / FCF Ratio | 45.82 | 0.01 | ||||
| Net Debt / Equity Ratio | 0.28 | 0.46 | 0.17 | -0.33 | -0.47 | -0.66 |
| Net Debt / EBITDA Ratio | -1.39 | 3.36 | -2.67 | 1.28 | 3.36 | -5.35 |
| Net Debt / FCF Ratio | -20.67 | 16.81 | -1.02 | 1.60 | 4.51 | -4.14 |
| Asset Turnover | 0.22 | 0.21 | 0.12 | 0.03 | 0.04 | 0.26 |
| Quick Ratio | 3.92 | 3.19 | 5.01 | 8.65 | 8.88 | 7.27 |
| Current Ratio | 4.17 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 |
| Return on Equity (ROE) | -23.40% | 34.12% | -16.20% | -38.39% | -12.86% | 13.84% |
| Return on Assets (ROA) | -5.60% | 2.88% | -1.50% | -7.83% | -7.09% | 7.51% |
| Return on Invested Capital (ROIC) | -15.93% | 9.14% | -7.03% | -37.36% | -30.58% | 48.77% |
| Return on Capital Employed (ROCE) | -9.90% | 4.80% | -2.80% | -10.90% | -13.00% | 11.40% |
| Earnings Yield | 2.81% | 9.63% | -4.46% | -19.21% | -8.12% | 6.70% |
| FCF Yield | 0.96% | 0.87% | -4.45% | -8.55% | -6.11% | 9.62% |
| Payout Ratio | 17.26% | 22.15% | ||||
| Buyback Yield / Dilution | -51.64% | -53.68% | -2.00% | -0.51% | 6.39% | -5.99% |